ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.473,63
1,32%
S&P 500
5.741,62
-0,07%
Dow Jones
42.366,27
0,45%
Euro vs US Dollar
1,1167
-0,08%
Bitcoin
65.801,27
0,95%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) News

XRTX

XORTX Therapeutics (XRTX)

XORTX Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:XRTX
DatumZeitQuelleÜberschriftSymbolFirma
24/09/202412h12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202412h09Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202412h06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202412h06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202412h03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
24/09/202412h03Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/09/202422h20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
13/09/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
13/09/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
13/09/202413h00GlobeNewswire Inc.XORTX Announces Results of Annual and Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
12/09/202423h30GlobeNewswire Inc.XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&ANASDAQ:XRTXXORTX Therapeutics Inc
06/09/202423h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
06/09/202423h30GlobeNewswire Inc.XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
03/09/202418h30GlobeNewswire Inc.Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
29/08/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
29/08/202413h00GlobeNewswire Inc.XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine MetabolismNASDAQ:XRTXXORTX Therapeutics Inc
23/08/202414h13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
23/08/202413h00GlobeNewswire Inc.XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
22/08/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
20/08/202421h11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
20/08/202413h00GlobeNewswire Inc.XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024NASDAQ:XRTXXORTX Therapeutics Inc
12/07/202422h06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
12/07/202422h05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202422h19Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202422h18Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202422h17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202422h15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202422h14Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202422h13Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
13/06/202422h12Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:XRTXXORTX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:XRTX

Kürzlich von Ihnen besucht

TG
TUI1
Tui
COIN
ETHUSD
Ethereum
USOTC
BASFY
BASF (QX)
TG
ALV
Allianz
NYSE
XOM
Exxon Mobil
NYSE
NKE
Nike
AMEX
XLV
Health Care Select Sector
DBI
TDXP
Tec DAX
NYSE
KO
Coca Cola
CCOM
US500
US 500
TG
NOV
Novo Nordisk
TG
D7G
Nel ASA
USOTC
ADDYY
Adidas (QX)
FX
EURGBP
Euro vs Sterling
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten